Axiom Energy, backed by the Stanford-StartX Fund, has received series A capital from a consortium including corporates Great Plains Energy and Shell.

The government-owned Scottish Investment Bank has returned to pour more funding into Strathclyde mycoprotein spinout 3F Bio.

Parkwalk Advisors has returned from earlier rounds to help drive the UEA spinout's bid for additional markets for its image augmentation technology.

Partially based on research at Duke University, Camras Vision is working on a treatment for refractory glaucoma.

Zapata, which remains in stealth mode, filed a security filing naming two of its directors as partners from MIT's the Engine and VC firm Pillar.

Frazier Healthcare Partners has led a $9.3m funding round in Penn spinout Scout Bio.

KU Leuven returned for the automated DNA diagnostic spinout's series A round, which follows a $2.3m round in 2016 and $1.5m raised in 2015.